Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belinostat + Bortezomib in Relapsed/Refractory Multiple Myeloma
NCT00431340Phase 2Terminated
- Sponsor
- Valerio Therapeutics
- Start
- Mar 2007
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belinostat in multiple myeloma (MM), sponsored by Valerio Therapeutics. Started Mar 2007; status: terminated.
02
Drugs
belinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00431340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431340.